Strategies to improve quality of life in bladder cancer patients

被引:3
作者
Roaldsen, Marius [1 ,2 ]
Aarsaether, Erling [1 ,2 ]
Knutsen, Tore [1 ]
Patel, Hiten R. H. [1 ,2 ]
机构
[1] Univ Hosp North Norway, Dept Urol & Endocrine Surg, N-9038 Tromso, Norway
[2] Univ Tromso, Inst Clin Med, N-9037 Tromso, Norway
关键词
bladder cancer; ERAS; evidence-based medicine; guidelines; oncology; quality of life; shared decision-making; INVASIVE UROTHELIAL CARCINOMA; TRANSURETHRAL RESECTION; RADICAL CYSTECTOMY; URINARY-DIVERSION; DECISION AIDS; CHEMOTHERAPY; THERAPY; PRESERVATION; GUIDELINES; RADIATION;
D O I
10.1586/14737167.2014.917967
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Bladder cancer is a heterogeneous disease that includes both tumors with low risk of dissemination as well as highly malignant tumors with a considerable potential to metastasize. The patient's quality of life is closely related to the management of the disease. The challenge for the urologist is to acknowledge the malignant potential of the cancer and to adjust the approach to the patient accordingly. Patients with low-risk bladder cancer should avoid an exaggerated follow-up, but on the other hand high-risk patients must be sufficiently surveyed to secure that definitive surgical treatment is performed before it's too late. When the decision to perform a cystectomy has been made, it is crucial that the patient understands the consequences of the surgery as well as the possible options for urinary reconstruction. This review focuses on aspects of bladder cancer management that we believe are vital for the quality of life of these patients.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 63 条
  • [41] Metcalfe M, 2013, CAN J UROL, V20, P6626
  • [42] Muscle Invasive Bladder Cancer: From Diagnosis to Survivorship
    Mohamed, N. E.
    Diefenbach, M. A.
    Goltz, H. H.
    Lee, C. T.
    Latini, D.
    Kowalkowski, M.
    Philips, C.
    Hassan, W.
    Hall, S. J.
    [J]. ADVANCES IN UROLOGY, 2012, 2012
  • [43] Muscle Invasive Bladder Cancer: Examining Survivor Burden and Unmet Needs
    Mohamed, Nihal E.
    Herrera, Phapichaya Chaoprang
    Hudson, Shawna
    Revenson, Tracey A.
    Lee, Cheryl T.
    Quale, Diane Z.
    Zarcadoolas, Christina
    Hall, Simon J.
    Diefenbach, Michael A.
    [J]. JOURNAL OF UROLOGY, 2014, 191 (01) : 48 - 53
  • [44] Prospective Randomized Controlled Trial of Robotic versus Open Radical Cystectomy for Bladder Cancer: Perioperative and Pathologic Results
    Nix, Jeff
    Smith, Angela
    Kurpad, Raj
    Nielsen, Matthew E.
    Wallen, Eric M.
    Pruthi, Raj S.
    [J]. EUROPEAN UROLOGY, 2010, 57 (02) : 196 - 201
  • [45] OLSEN LH, 1995, SCAND J UROL NEPHROL, P33
  • [46] Enhanced Recovery After Surgery: Are We Ready, and Can We Afford Not to Implement These Pathways for Patients Undergoing Radical Cystectomy?
    Patel, Hitendra R. H.
    Cerantola, Yannick
    Valerio, Massimo
    Persson, Beata
    Jichlinski, Patrice
    Ljungqvist, Olle
    Hubner, Martin
    Kassouf, Wassim
    Muller, Stig
    Baldini, Gabriele
    Carli, Francesco
    Naesheim, Torvind
    Ytrebo, Lars
    Revhaug, Arthur
    Lassen, Kristoffer
    Knutsen, Tore
    Aarsaether, Erling
    Wiklund, Peter
    Catto, James W. F.
    [J]. EUROPEAN UROLOGY, 2014, 65 (02) : 263 - 266
  • [47] Laparoscopic and robot-assisted continent urinary diversions (Mitrofanoff and Yang-Monti conduits) in a consecutive series of 15 adult patients: the Saint Augustin technique
    Rey, Denis
    Helou, Elie
    Oderda, Marco
    Robbiani, Jacopo
    Lopez, Laurent
    Piechaud, Pierre-Thierry
    [J]. BJU INTERNATIONAL, 2013, 112 (07) : 953 - 958
  • [48] Hexyl Aminolevulinate-Guided Fluorescence Cystoscopy in the Diagnosis and Follow-up of Patients with Non-Muscle-invasive Bladder Cancer: A Critical Review of the Current Literature
    Rink, Michael
    Babjuk, Marko
    Catto, James W. F.
    Jichlinski, Patrice
    Shariat, Shahrokh F.
    Stenzl, Arnulf
    Stepp, Herbert
    Zaak, Dirk
    Witjes, J. Alfred
    [J]. EUROPEAN UROLOGY, 2013, 64 (04) : 624 - 638
  • [49] Selective bladder preservation by trimodality therapy for patients with muscularis propria-invasive bladder cancer and who are cystectomy candidates - The Massachusetts General Hospital and Radiation Therapy Oncology Group Experiences
    Shipley, WU
    Zietman, AL
    Kaufman, DS
    Coen, JJ
    Sandler, HM
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2005, 15 (01) : 36 - 41
  • [50] Skea ZC, 2013, EUR J ONCOL NURS, V18, P35